Characterization of Clinical Outcomes in Patients with Cutis Marmorata Telangiectatica Congenita
Main Article Content
Keywords
Vascular Malformation
Abstract
Cutis marmorata telangiectatica congenita (CMTC) is an uncommon, congenital, cutaneous vascular disease with an unknown pathogenesis. Although considered as a benign condition, anomalies such as body asymmetry are frequently associated. Herein we present a series of patient with diagnosis of CMTC with a focus on clinical outcomes. In our series, limb length abnormalities were the most common associate anomaly, occurring in 24% of the subjects, similar to other series with rates of 33% and 27% but higher than the general population (6.7%). Importantly, dermatologist should be aware of the frequently associated anomalies in CMTC, such as leg length discrepancy, which may have serious consequences if not recognized and treated.
References
2. Amitai DB, Fichman S, Merlob P, Morad Y, Lapidoth M, Metzker A. Cutis marmorata telangiectatica congenita: clinical findings in 85 patients. Pediatr Dermatol. 2000;17(2):100-4.
3. Kienast AK, Hoeger PH. Cutis marmorata telangiectatica congenita: a prospective study of 27 cases and review of the literature with proposal of diagnostic criteria. Clin Exp Dermatol. 2009;34(3):319-23.
4. Memarzadeh A, Pengas I, Syed S, Eastwood DM. Limb length discrepancy in cutis marmorata telangiectatica congenita: an audit of assessment and management in a multidisciplinary setting. Br J Dermatol. 2014;170(3):681-6.
5. del Boz Gonzalez J, Serrano Martin MM, Vera Casano A. [Cutis marmorata telangiectatica congenita. Review of 33 cases]. An Pediatr (Barc). 2008;69(6):557-64.
6. Drnach M, Kreger A, Corliss C, Kocher D. Limb length discrepancies among 8- to 12-year-old children who are developing typically. Pediatr Phys Ther. 2012;24(4):334-